Pathstone Holdings’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-16,871
Closed -$243K – 2266
2024
Q4
$243K Buy
16,871
+571
+4% +$8.84K ﹤0.01% 2069
2024
Q3
$258K Buy
16,300
+530
+3% +$8.36K ﹤0.01% 2048
2024
Q2
$242K Buy
+15,770
New +$239K ﹤0.01% 2053
2024
Q1
– Sell
-15,143
Closed -$222K – 2302
2023
Q4
$222K Buy
+15,143
New +$211K ﹤0.01% 2016

Other funds holding BMEZ

Pathstone Holdings's BMEZ Position: Q1 2025 in Review

Pathstone Holdings sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2025, closing a stake of 16,871 shares — an estimated $243K sold.

Pathstone Holdings first reported a position in BMEZ in Q4 2023 and held it in 4 quarters. The position peaked at $258K in Q3 2024. 99 funds tracked by Wall St. Rank hold BMEZ as of Q1 2025.

  • Pathstone Holdings reported no remaining BlackRock Health Sciences Trust II position as of Q1 2025 after selling out during the quarter.
  • Pathstone Holdings sold 16,871 BlackRock Health Sciences Trust II shares in Q1 2025, an estimated $243K.
  • Pathstone Holdings first reported a position in BlackRock Health Sciences Trust II in Q4 2023 and held it in 4 quarters.
  • Pathstone Holdings's BlackRock Health Sciences Trust II position peaked at $258K in Q3 2024.
  • 99 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2025.

Based on Pathstone Holdings's 13F filing for Q1 2025, filed 15 May 2025.